Your English writing platform
Discover LudwigExact(60)
This combination was evaluated clinically.METHODS: We conducted a phase 1b study involving patients with relapsed or refractory non-Hodgkin's lymphoma.
The authors conducted a Phase I trial of escalating doses of CP using probenecid as a chemoprotector.
We conducted a phase II study of belinostat in patients with relapsed malignant pleural mesothelioma.
We conducted a phase II study of bortezomib in patients with advanced-stage BAC.
We conducted a phase I-II study of transplantation conditioning with clofarabine-melphalan-alemtuzumab for patients with advanced hematologic malignancies.
We conducted a Phase 1 study to evaluate the safety and pharmacokinetics of the combination in patients with hepatocellular carcinoma.
We conducted a phase I trial of maintenance sorafenib after HSCT in patients with FLT3-ITD AML (ClinicalTrials.gov NCT01398501).
Based on these findings, we conducted a phase 1 study of AzaC post DLI for AML relapse post allo-SCT.
We conducted a phase I clinical trial testing this approach in patients with metastatic renal cell carcinoma.
We conducted a phase I, first-in-human, open-label study with dose escalation (part 1) and dose expansion (part 2), which assessed the safety, pharmacokinetics (PK) and preliminary clinical activity of GSK2857916 monotherapy in patients with relapsed/refractory MM.
METHODS: We conducted a phase I/II trial of plerixafor on hematopoietic cell recovery following myeloablative allogeneic HSCT.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com